986 filings
Page 3 of 50
4
iuit f1kkiohmuyv
1 Dec 23
SEELOS THERAPEUTICS / Michael Joseph Golembiewski ownership change
4:16pm
4
eq0olxplv3nw
1 Dec 23
SEELOS THERAPEUTICS / Raj Mehra ownership change
4:16pm
8-K
0vzz489to4 r9o3
1 Dec 23
Seelos Therapeutics Announces Closing of Public Offering
4:08pm
8-K
dlj3r
30 Nov 23
Seelos Therapeutics Announces Pricing of $5.55 Million Public Offering
4:59pm
424B5
c18278rv3v4ylp
30 Nov 23
Prospectus supplement for primary offering
4:58pm
424B5
ocz95e6dqj4gm8hrdz
28 Nov 23
Prospectus supplement for primary offering
4:06pm
424B3
6vhphwbo
28 Nov 23
Prospectus supplement
4:03pm
8-K
ht9bbyjov8sekhn0leq
28 Nov 23
Material Modifications to Rights of Security Holders
9:00am
8-K
g1pbhq
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
12:07pm
8-K
hjomgbrsj0jm
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
11:10am
8-K
rr9nguktxoh9xnf
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
g5sh2 2v3
2 Oct 23
Entry into a Material Definitive Agreement
6:03am
EFFECT
tv6rb3
2 Oct 23
Notice of effectiveness
12:15am
424B3
zobr4bat ofc
29 Sep 23
Prospectus supplement
4:56pm
CORRESP
2ytvn2bbn r9bs
26 Sep 23
Correspondence with SEC
12:00am
8-K
tl41ltm
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
o2szm0d 77h2
25 Sep 23
Prospectus supplement for primary offering
6:02am